| Oct 21 |
Accuray Appoints Michael Murphy as VP, Corporate Controller
|
| Oct 17 |
New England Journal of Medicine Study Reaffirms Five Session Radiation Treatment Provides Comparable Rates of Cancer Control, Tolerability and Sexual Functioning to Conventional Radiotherapy Treatment in Men with Localized Prostate Cancer
|
| Oct 15 |
Accuray CEO Suzanne Winter returns from medical leave of absence
|
| Oct 15 |
Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence
|
| Sep 30 |
Genolier Health Innovation Hub opens in Switzerland
|
| Sep 30 |
Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training
|
| Sep 17 |
Here's Why You Should Retain Accuray Stock in Your Portfolio Now
|
| Sep 10 |
Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution
|
| Aug 28 |
Accuray Stock Rises After Helix System Wins CE Mark for Cancer Care
|
| Aug 28 |
Accuray’s helical radiation delivery system secures CE Mark approval
|
